Cristina Fernandez-Valle
Affiliations: | University of Central Florida, Orlando, FL, United States |
Area:
Molecular Biology, Neuroscience BiologyGoogle:
"Cristina Fernandez-Valle"Mean distance: 53433
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Fernandez-Valle C, Nagel A, Huegel J, et al. (2023) Simultaneous Inhibition of PI3K and PAK in Preclinical Models of Neurofibromatosis Type 2-related Schwannomatosis. Research Square |
Hardin HM, Dinh CT, Huegel J, et al. (2023) Co-targeting Phosphoinositide 3-Kinase and Focal Adhesion Kinase Pathways Inhibits Proliferation of NF2 Schwannoma Cells. Molecular Cancer Therapeutics |
Huegel J, Dinh CT, Martinelli M, et al. (2022) CUDC907, a dual phosphoinositide-3 kinase/histone deacetylase inhibitor, promotes apoptosis of NF2 Schwannoma cells. Oncotarget. 13: 890-904 |
Chang LS, Oblinger JL, Smith AE, et al. (2021) Brigatinib causes tumor shrinkage in both NF2-deficient meningioma and schwannoma through inhibition of multiple tyrosine kinases but not ALK. Plos One. 16: e0252048 |
Ein L, Bracho O, Mei C, et al. (2019) Inhibition of tropomyosine receptor kinase B on the migration of human Schwann cell and dispersion of oral tongue squamous cell carcinoma in vitro. Head & Neck |
Pestoni JC, Klingeman Plati S, Valdivia Camacho OD, et al. (2019) Peroxynitrite supports a metabolic reprogramming in merlin-deficient Schwann cells and promotes cell survival. The Journal of Biological Chemistry |
Fuse MA, Dinh CT, Vitte J, et al. (2019) Preclinical Assessment of MEK1/2 Inhibitors for Neurofibromatosis Type 2-Associated Schwannomas Reveal Differences in Efficacy and Drug Resistance Development. Neuro-Oncology |
Perez ER, Bracho O, Ein L, et al. (2018) Fluorescent Detection of Merlin-deficient Schwann Cells and Primary Human Vestibular Schwannoma Cells Using Sodium Fluorescein. Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology |
Allaway R, Angus SP, et al. (2018) Traditional and systems biology based drug discovery for the rare tumor syndrome neurofibromatosis type 2. Plos One. 13: e0197350 |
Dinh CT, Bracho O, Mei C, et al. (2018) A Xenograft Model of Vestibular Schwannoma and Hearing Loss. Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology |